NCT06098872View on ClinicalTrials.gov

Pilot Study on Trametinib for Surgical Unruptured AVMs

PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 30, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Arteriovenous Malformations
Interventions
DRUG

Trametinib tablet

Drug is supplied in 2mg and 0.5 mg tablets

Trial Locations (1)

Unknown

RECRUITING

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER